Key result
Admission glucose levels ≥190 mg/dL in STEMI patients undergoing primary PCI predicted higher in-hospital mortality compared to levels <190 mg/dL (OR 2.74; 95% CI 1.4-5.5; P=0.004).
Why the study?
Does admission hyperglycemia predict poorer short- and long-term outcomes in STEMI patients undergoing primary PCI?
Population
959 consecutive ST-elevation myocardial infarction patients undergoing primary percutaneous coronary…
Comparison
Admission hyperglycemia vs Lower admission glucose levels (e.g., <190 mg/dL)
Design
Cohort
Authors
Loading...
May warrant closer monitoring in hyperglycemic STEMI patients; leaves open whether intervention alters prognosis.
Cohort (n=959)
Does admission hyperglycemia predict poorer short- and long-term outcomes in STEMI patients undergoing primary PCI?
Effect estimate: OR 2.74 (95% CI 1.4-5.5)
p-value: p=0.004
Admission hyperglycemia, particularly ≥190 mg/dL, is a strong predictor of increased in-hospital and long-term mortality and morbidity in STEMI patients undergoing primary PCI.
Chen et al. (2013) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=959). Admission glucose levels ≥190 mg/dL vs. Admission glucose levels <190 mg/dL was evaluated on In-hospital mortality (OR 2.74, 95% CI 1.4-5.5, p=0.004). Admission glucose levels ≥190 mg/dL in STEMI patients undergoing primary PCI predicted higher in-hospital mortality compared to levels <190 mg/dL (OR 2.74; 95% CI 1.4-5.5; P=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: